Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition
Cardiovascular Research · 2024
DOI: 10.1093/cvr/cvae138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Lu-Jun Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Changhai Hospital, 168 Changhai Road, Shanghai 200433, China. Hauptthemen laut MEDLINE: Blood Platelets, Disease Models, Animal, MicroRNAs, Myocardial Infarction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Aims
MicroRNA-126 (miR-126), one of the most abundant microRNAs in platelets, is involved in the regulation of platelet activity and the circulating miR-126 is reduced during antiplatelet therapy. However, whether intraplatelet miR-126 plays a role in thrombosis and platelet inhibition remains unclear. Methods and results Here, using tissue-specific knockout mice, we reported that the deficiency of miR-126 in platelets and vascular endothelial cells significantly prevented thrombosis and prolonged bleeding time. Using chimeric mice, we identified that the lack of intraplatelet miR-126 significantly prevented thrombosis. Ex vivo experiments further demonstrated that miR-126-deficient platelets displayed impaired platelet aggregation, spreading, and secretory functions. Next, miR-126 was confirmed to target phosphoinositol-3 kinase regulatory subunit 2 (PIK3R2) in platelet, which encodes a negative regulator of the phosphoinositide 3-kinase/protein kinase B pathway, enhancing platelet activation through activating the integrin αIIbβ3-mediated outside-in signalling. After undergoing myocardial infarction (MI), chimeric mice lacking intraplatelet miR-126 displayed reduced microvascular obstruction and prevented MI expansion in vivo. In contrast, overexpression of miR-126 by the administration of miR-126 agonist (agomiR-126) in wild-type mice aggravated microvascular obstruction and promoted MI expansion, which can be almost abolished by aspirin administration. In patients with cardiovascular diseases, antiplatelet therapies, either aspirin alone or combined with clopidogrel, decreased the level of intraplatelet miR-126. The reduction of intraplatelet miR-126 level was associated with the decrease in platelet activity.
Conclusion
Our murine and human data reveal that (i) intraplatelet miR-126 contributes to platelet activity and promotes thrombus formation, and (ii) the reduction of intraplatelet miR-126 contributes to platelet inhibition during antiplatelet therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai Changhai Hospital, 168 Changhai Road, Shanghai 200433, China.
- Department of Cardiology, Shanghai Changzheng Hospital, Shanghai, China.
- Department of Geriatrics, Second Hospital Affiliated to Chongqing Medical University, Chongqing Medical University, Chongqing, China.
- Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- CAS Key Laboratory of Tissue Microenvironment and Tumor, Innovation Center for Intervention of Chronic Disease and Promotion of Health, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Scienc…
- Department of Cardiology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Zhi-Fu Guo, Qing Jing
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zhang, L. J., Hu, Y. X., Huang, R. Z., Xu, Y. Y., Dong, S. H., Guo, F. H., Guo, J. J., Qiu, J. J., Cao, Z. Y., Wei, L. J., Mao, J. H., Lyu, A., Liu, J. L., Zhao, X. X., Guo, Z. F., & Jing, Q. (2024). Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae138
Vancouver
Zhang LJ, Hu YX, Huang RZ, Xu YY, Dong SH, Guo FH, et al. Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae138
BibTeX
@article{Zhang2024,
author = {Zhang, Lu-Jun and Hu, Yang-Xi and Huang, Rong-Zhong and Xu, Yan-Yan and Dong, Shao-Hua and Guo, Fang-Hao and Guo, Jun-Jun and Qiu, Jing-Jing and Cao, Zi-Yun and Wei, Li-Jiang and Mao, Jia-Hao and Lyu, Ankang and Liu, Jun-Ling and Zhao, Xian-Xian and Guo, Zhi-Fu and Jing, Qing},
title = {Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition},
journal = {Cardiovascular Research},
year = {2024},
doi = {10.1093/cvr/cvae138}
}
EUVIMED